Health Sector/Insurance

Meet Binney Street Capital: Dana-Farber Cancer Institute’s first venture fund – Fierce Biotech

Screen Shot 2021-01-15 at 9.22.33 PM

Written by Ben Adams

The Dana-Farber Cancer Institute is getting into the life science funding biz with the launch of its venture arm Binney Street Capital.

Dana-Farber is certainly no stranger to backing biotechs and teaming up with other VCs; …

By Profile Picture
Read more »

Atrius Health, state’s largest independent physician group, is in acquisition talks – Boston Business Journal

Screen Shot 2021-01-15 at 8.37.01 PM

Written by Jessica Bartlett

One of the nation’s largest physician groups is in the works to acquire the state’s largest independent doctor group, a decision that would further cement the national group’s presence in Massachusetts.

Optum, the for-profit health provider …

By Profile Picture
Read more »

JPM: Bluebird to spin off cancer therapies into new company – Fierce Biotech

Screen Shot 2021-01-14 at 5.16.02 PM

Written by Nick Paul Taylor

Bluebird bio is planning to spin off its oncology assets into a new publicly traded company. The move follows a series of operational missteps that have delayed patient access to once-hyped therapies.

Today, bluebird’s pipeline …

By Profile Picture
Read more »

Health care startup launched by Amazon, JP Morgan, Berkshire Hathaway disbands – Boston Business Journal

Screen Shot 2021-01-11 at 5.47.46 PM

Written by Jessica Bartlett

Haven, the health care startup launched by Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. three years ago with much fanfare, announced on Monday that it would disband, leaving the three companies to solve the problems …

By Profile Picture
Read more »

AstraZeneca snaps up Alexion for $39B in a leap toward CEO’s $40B revenue goal – Fierce Pharma


Written by Angus Liu

Just when Gilead Sciences’ $21 billion acquisition of Immunomedics looked to be 2020’s biggest biopharma deal, AstraZeneca came up with an even larger one—and it involves one of the industry’s top takeover targets.

AstraZeneca is splashing out $39 …

By Maria Ordonez
Maria Ordonez Profile Picture
Read more »


Recent News

Career Resources